Early Warning Signs and Symptoms for Screening and Diagnosing Pulmonary Tuberculosis Among Diabetes Mellitus Patients in Phukhieo-Chalermpragiet Hospital, Chaiyaphum Province

Main Article Content

อเนก หล้าเพชร ปิยะนุช พรหมสาขา ณ สกลนคร

Abstract

    This retrospective case control research study aimed to investigate  early warning signs and symptoms for screening and diagnosing pulmonary tuberculosis in Diabetes  Mellitus patients using medical records.  The participants were divided into 2 groups. The study group consisted of 59 pulmonary tuberculosis with Diabetes Mellitus patients (DM/PTB) and the control group  included 166  Diabetes Mellitus patients without tuberculosis (non-DM/PTB). Comparative statistics with Odd Ratios (OR) under 95 percent  confidence  interval was used for data analysis. It was found that the prevalence rate of new pulmonary tuberculosis in Diabetes Mellitus was 14.99 cases per 1,000 diabetes mellitus, prevalence rate of pulmonary tuberculosis in male and female Diabetes Mellitus patients accounted for 7.62 and 7.33 cases per 1,000 diabetes mellitus. Mostly were in the age range of 50-59 years, representing 59 cases per 1,000 diabetes mellitus and living outside the municipality, representing 12.45 cases per 1,000 diabetes mellitus.  Clinical signs and symptoms for screening and diagnosing pulmonary tuberculosis in diabetic patients were anorexia or eating unhealthy food, low fever or chronic fever, weight loss more than 3 kilograms in 3 months, frequent hypoglycemia, chronic cough  and  possession of Glycated hemoglobin (HbA1c)  higher than 8.5 milligrams per cent.  The results showed that Pulmonary tuberculosis prevalence rate in diabetic patients was at a high level. The findings suggest that screening clinical signs and symptoms for all diabetic patients should be addressed. Early investigation and diagnosis  of Pulmonary tuberculosis in diabetic patients will be useful for patients to receive fast treatment  and prevent  further spread of Pulmonary tuberculosis.

Keywords

Article Details

How to Cite
1.
หล้าเพชรอ, ณ สกลนครป. Early Warning Signs and Symptoms for Screening and Diagnosing Pulmonary Tuberculosis Among Diabetes Mellitus Patients in Phukhieo-Chalermpragiet Hospital, Chaiyaphum Province. Nursing Journal of The Ministry of Public Health [Internet]. 31Aug.2019 [cited 10Dec.2019];29(2):64-3. Available from: https://www.tci-thaijo.org/index.php/tnaph/article/view/213649
Section
บทความวิจัย

References

1. World Health Organization. Global tuberculosis report 2017. Geneva, Switzerland: (WHO/ HTM/TB/2017.23)

2. Bureau of tuberculosis. Department of Disease Control. Ministry of Public Health. TB control guidelines for Thailand 2018. Graphic Arts and Design Publishing.2018. (in Thai)

3. Bureau of tuberculosis. Department of Disease Control. Systematic screening for active TB and drug-resistant TB. Graphic Arts and Design Publishing(2nd edition). 2018. (in Thai)

4. Marais BJ, Lnnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis. 2013;13(5):436-48. DOI:10.1016/S1473-3099(13)70015-X

5. Orofino RL, Brasil PEAd, Trajman A, Schmaltz CAS, Dalcolmo M, Rolla VC. Preditores of tuberculosis treatment outcomes. J Bras Pneumol.2012;38(1):88-97. DOI:10.1590/S1806-37132012000100013

6. Silva PF, Moura GS, Caldas AJM. Factors associated with pulmonary TB treatment dropout in Maranhão State, Brazil, from 2001 to 2010. Cad Saude Publica. 2014;30(8):1745-54. DOI:10.1590/0102-311X00124513.

7. Namwat C, KhamLuang S, Pradithsitthikorn N, Laowsirithaworn Y, MaraeKhein S, Pintadit V et al. Return on investment of ending TB strategies in Thailand: a cost-benefit analysis. World Fund Management Office. Department of Disease Control. Ministry of Public health. Department
of Disease Control, Ministry of Public Health and HITAP. 2017.(in Thai)

8. Mi F, Tan S, Liang L, Harries AD, Hinderaker SG, Lin Y et al. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou,China. Trop Med Int Health.2013;18(1):379-85. DOI:10.1111/tmi.12198

9. Jeon CY, Murray MB. Diabetes Mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7): e152.DOI:10.1371 /journal. pmed.0050152

10. Ruslami R, Aarnoutse RE, Alisjahbana B, Ven AJ, Crevel R. Implications of the global increase Of diabetes for tuberculosis control and patient care. Trop Med Int Health. 2010;15(11):1289-99. DOI:10.1111/j.1365-3156.2010.02625.x

11. Aupachak S, Pichensathian W, Chitreecheur J. Efficacy of hospital pulmonary tuberculosis screening form. Nursing Journal.2016;43:107-17.(in Thai)

12. Department of Disease Control. Ministry of Public health. Tuberculosis incidence in Thailand. [cited 2019 April 30]. Available from https://www.tbthailand.org/download/Factsheet_TB%20 Situation2017.pdf.(in Thai)

13. Choksawatd P, Suggaravetsiri P. Factors correlated to pulmonary tuberculosis among diabetes mellitus patients in Chaiyaphum Province. Journal of the Office of DPC6 Khonkaen. 2011;18(1) :38-47.(in Thai)

14. World Tuberculosis Fund Project. TB screening in diabetes clinic. [cited 2019 April 20]. Available from http://www.tbnfmthailand.org/index.php?option=com_ content&view=article&id=47&Itemid=56

15. Mario C. Raviglione. Harrison principle of internal of medicine: chapter 202 tuberculosis.19 th edition. New Jersey: McGraw-Hill; 2015

16. Kheawkhumsaen P, Suggaravetsiri P. Prevalence and factors associated with pulmonary tuberculosis among diabetes mellitus patients in Sakonnakhon province. KKU Journal for Public Health Research. 2013;6(2):90-9. (in Thai)

17. Khuancharee K, Suggaravetsiri P, Trinnawoottipong K. Factors associated with smear positive pulmonary tuberculosis among diabetes mellitus patients in Thailand: A meta-analysis. Journal of the office of DPC7 Khon Kaen. 2016;23(3): 1-11.(in Thai)

18. World Health Organization. Systematic screening for active tuberculosis, an operation guide. Geneva Switzerland: WHO; 2015